0.58
Travere Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
billions USD
FY21:
FY22:
0.49
FY23:
0.62
FY24:
0.42
FY25:
0.44
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.19
FY22:
0.19
FY23:
0.17
FY24:
0.18
FY25:
0.17
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.78
FY22:
0.67
FY23:
0.79
FY24:
0.59
FY25:
0.61
Liabilities & Equity
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.12
FY22:
0.14
FY23:
0.18
FY24:
0.20
FY25:
0.16
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.35
FY22:
0.49
FY23:
0.41
FY24:
0.33
FY25:
0.33
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.30
FY22:
0.04
FY23:
0.20
FY24:
0.06
FY25:
0.11
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.78
FY22:
0.67
FY23:
0.79
FY24:
0.59
FY25:
0.61
All amounts in billions USD